Table 2.
ELLA assay outcomes (S2.1‐S2.34) deriving from 2 different sources of antigens (N2 NA). Average of the results are also showed
Test 1 | Test 2 | Test 1 | Test 2 | AVG | AVG | |
---|---|---|---|---|---|---|
Serum ID | H11N2‐PV | H11N2‐PV | H6N2 | H6N2 | H11N2‐PV | H6N2 |
S2.1 | 320 | 640 | 160 | 160 | 453 | 160 |
S2.2 | 20 | 20 | 20 | 20 | 20 | 20 |
S2.3 | 10 | 10 | 10 | 10 | 10 | 10 |
S2.4 | 80 | 160 | 40 | 40 | 113 | 40 |
S2.5 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.6 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.7 | 40 | 40 | 40 | 40 | 40 | 40 |
S2.8 | 80 | 80 | 80 | 80 | 80 | 80 |
S2.9 | 40 | 40 | 20 | 20 | 40 | 20 |
S2.10 | 20 | 20 | 40 | 40 | 20 | 40 |
S2.11 | 40 | 40 | 40 | 40 | 40 | 40 |
S2.12 | 10 | 10 | 10 | 10 | 10 | 10 |
S2.13 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.14 | 10 | 10 | 5 | 10 | 10 | 7 |
S2.15 | 80 | 40 | 40 | 40 | 57 | 40 |
S2.16 | 40 | 20 | 40 | 40 | 28 | 40 |
S2.17 | 10 | 20 | 10 | 10 | 14 | 10 |
S2.18 | 10 | 10 | 5 | 5 | 10 | 5 |
S2.19 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.20 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.21 | 320 | 320 | 80 | 160 | 320 | 113 |
S2.22 | 320 | 160 | 80 | 80 | 226 | 80 |
S2.23 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.24 | 40 | 40 | 20 | 20 | 40 | 20 |
S2.25 | 10 | 10 | 10 | 10 | 10 | 10 |
S2.26 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.27 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.28 | 640 | 640 | 320 | 320 | 640 | 320 |
S2.29 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.30 | 320 | 320 | 160 | 160 | 320 | 160 |
S2.31 | 160 | 160 | 160 | 160 | 160 | 160 |
S2.32 | 40 | 20 | 20 | 20 | 28 | 20 |
S2.33 | 5 | 5 | 5 | 5 | 5 | 5 |
S2.34 | 5 | 5 | 5 | 5 | 5 | 5 |
HP‐HS‐N2 | 1280 | 1280 | 2560 | 2560 | 1280 | 2560 |
Minus | 5 | 5 | 5 | 5 | 5 | 5 |